Film Financing & Partnerships
Invest in genre films that travel.
Exit 44 Entertainment finances, produces, and sells horror and action films worldwide. We partner with qualified investors and co-financiers who want disciplined exposure to one of independent film’s most resilient categories.
Why Genre
A financing thesis built on efficiency
Horror and elevated genre films punch above their budgets: lean costs, loyal global audiences, and long revenue tails across theatrical, streaming, and television. We underwrite each film against real, verifiable value — pre-sales, incentives, and distribution interest — before committing capital.
Because we sit at every stage — production, financing, and worldwide sales — our incentives are aligned with our partners’ from first dollar to final collection.
Equity Co-Financing
Partner alongside Exit 44 on a single film or a slate, sharing in the upside of worldwide distribution revenue.
Gap & Bridge
Complete a film’s budget against pre-sales and tax incentives with structured, collateralized positions.
P&A / Release
Fund prints-and-advertising and release costs on titles with distribution already in place.
Film financing & investment FAQ
How does film financing work with Exit 44?
Can I invest in an Exit 44 film?
Why genre and horror films?
Are film investments risky?
What is a co-production or financing partnership?
How do I start a conversation about investing?
Explore a partnership
Tell us about your goals and we’ll walk you through current opportunities and structures.
Disclaimer: The information on this page is provided for general informational purposes only and does not constitute an offer to sell, or the solicitation of an offer to buy, any security, nor investment, legal, tax, or financial advice. Any film investment or financing opportunity is offered only to qualified and/or accredited investors pursuant to definitive documentation and applicable law. Investing in film involves substantial risk, including the possible loss of your entire investment; past performance is not indicative of future results. Prospective investors should consult their own professional advisors.